The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Compositions For The Treatment Of Cftr Mediated Diseases - EP2914248

The patent EP2914248 was granted to Vertex Pharmaceuticals Incorporated on Oct 18, 2023. The application was filed on Nov 1, 2013 under application number EP13792149A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2914248

VERTEX PHARMACEUTICALS INCORPORATED
Application Number
EP13792149A
Filing Date
Nov 1, 2013
Status
Patent Maintained As Amended
Sep 15, 2023
Publication Date
Oct 18, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Combination tablet therapy for treating cystic fibrosis using a specific ratio of two drugs, 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (Compound 1) and N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide (Compound 2). The tablet contains 100-200 mg Compound 1 Form I and 125 mg amorphous Compound 2. This combination provides balanced CFTR potentiation and correction for improved CFTR function in cystic fibrosis patients.

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKJun 4, 2019TER MEER STEINMEISTER & PARTNER -

Patent Citations (51) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2003144257
DESCRIPTIONUS2004105820
DESCRIPTIONUS2005164973
DESCRIPTIONUS2006035943
DESCRIPTIONUS2006148863
DESCRIPTIONUS2006148864
DESCRIPTIONUS2010074949
DESCRIPTIONUS6992096
DESCRIPTIONUS7202262
DESCRIPTIONUS7495103
DESCRIPTIONUS7741321
DESCRIPTIONUS8247436
DESCRIPTIONUS8507534
DESCRIPTIONWO2004028480
DESCRIPTIONWO2004080972
DESCRIPTIONWO2004091502
DESCRIPTIONWO2004110352
DESCRIPTIONWO2004111014
DESCRIPTIONWO2005035514
DESCRIPTIONWO2005049018
DESCRIPTIONWO2005094374
DESCRIPTIONWO2005120497
DESCRIPTIONWO2006002421
DESCRIPTIONWO2006044456
DESCRIPTIONWO2006044502
DESCRIPTIONWO2006044503
DESCRIPTIONWO2006044505
DESCRIPTIONWO2006044682
DESCRIPTIONWO2006099256
DESCRIPTIONWO2006101740
DESCRIPTIONWO2006110483
DESCRIPTIONWO2006127588
DESCRIPTIONWO2007044560
DESCRIPTIONWO2007056341
DESCRIPTIONWO2008135557
DESCRIPTIONWO2009073757
DESCRIPTIONWO2009074575
DESCRIPTIONWO2009150137
DESCRIPTIONWO2010019239
DESCRIPTIONWO2011028740
DESCRIPTIONWO2011079087
DESCRIPTIONWO2011113894
DESCRIPTIONWO2012035158
INTERNATIONAL-SEARCH-REPORTWO2009073757
INTERNATIONAL-SEARCH-REPORTWO2010019239
INTERNATIONAL-SEARCH-REPORTWO2013112804
OPPOSITIONUS2011256220
OPPOSITIONWO2009073757
OPPOSITIONWO2010019239
OPPOSITIONWO2010037066
OPPOSITIONWO2012147101

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents